NEW BRUNSWICK, N.J. (AP) - Johnson & Johnson said Monday it has agreed to buy Aragon Pharmaceuticals Inc. for at least $650 million in cash, boosting its position in prostate drug development.

LITTLE ROCK - Arkansas' attorney general filed a brief Tuesday backed by his counterparts in 35 other states asking the Arkansas Supreme Court to uphold a $1.2 billion fine levied against Johnson & Johnson and a subsidiary over the marketing of the ...

Ex-NFL star Chad Johnson was scolded for taking his domestic violence case lightly in court ... and now we have photos of his ex-wife Evelyn Lozada's face after the crime.

One of the biotech laggards of the year, Medivation (MDVN) saw a very high volume sell-off (down 6.78%, or $47.41/share) on Monday after rival Johnson & Johnson (JNJ) announced the acquisition of Aragon Pharmaceuticals. This company was developing ...

Johnson & Johnson got a lift on Monday after announcing it would buy the small, privately held drug discovery firm Aragon Pharmaceuticals Inc. for as much as $1 billion, but the health-care conglomerate ultimately won't have a stake in much of Aragon's ...

Johnson & Johnson, the world's biggest maker of health-care products, agreed to buy Aragon Pharmaceuticals Inc. and its experimental prostate cancer drug in a deal worth as much as $1 billion.

The already-successful new prostate cancer drug Zytiga is not solely responsible for turning around the fortunes of Johnson & Johnson's (JNJ) once-lackluster drug business, but it has certainly played an important role. Johnson & Johnson is now ...

NEW BRUNSWICK, N.J., June 17, 2013 -- /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today a definitive agreement to acquire Aragon Pharmaceuticals, Inc., a privately-held, pharmaceutical discovery and development company focused on ...

The Food and Drug Administration said today it approved a next-generation silicone breast implant from Mentor, a unit of New Brunswick-based Johnson & Johnson. The company's MemoryShape breast implant uses a cross-linking gel design that the FDA ...

China's food and drug safety regulator is taking Johnson & Johnson to task with claims that the US company has a shoddy quality-control system (link in Chinese).